advertising

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

News

ImmunityBio warned by FDA over 'misleading' Anktiva content

The FDA has sent a warning letter to ImmunityBio over "false and misleading" comments made by executive chair, billionaire Patrick Soon-Shiong.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

Novo Nordisk's Wegovy pill ad 'misleading', says FDA

Novo Nordisk has been criticised by the FDA for a TV ad for the Wegovy pill, which the agency claims makes "false and misleading" claims.

News

Indivior stops Opvee promotion in New York after settlement

Indivior has agreed to halt all marketing of its opioid overdose drug Opvee in New York after being rapped for mispromoting it to health officials.

News

Leaked MAHA draft signposts US health reform under Trump

A leaked version of the Make America Healthy Again programme for the Trump administration has plenty for the pharma industry to stew over.

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

ImmunityBio warned by FDA over 'misleading' Anktiva content

FDA ramps up its pushback against compounded GLP-1s

Novo Nordisk's Wegovy pill ad 'misleading', says FDA

Indivior stops Opvee promotion in New York after settlement

Leaked MAHA draft signposts US health reform under Trump

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

advertising

Editor's Picks